跳至主要内容
临床试验/NCT06767137
NCT06767137招募中不适用

Comparative Efficacy of Bedtime Restriction Therapy and Cognitive Behavioral Therapy for Insomnia - a Randomized Controlled Non-inferiority Trial

Christoph Nissen4 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2025年3月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
160
试验地点
4
主要终点
Insomnia Severity Index (ISI) summary scores

研究概览

简要总结

This study evaluates two behavioral treatments for patients with insomnia disorder: Bedtime Restriction Therapy (BRT) and Cognitive Behavioral Therapy for Insomnia (CBT-I). Both therapies aim to improve the clinical symptomatology of insomnia by teaching participants techniques to better manage their sleep schedule and habits. BRT is a simpler and shorter therapy focused on aligning the time spent in bed with reported sleep time. CBT-I includes additional components such as relaxation techniques and cognitive exercises. The study will compare these treatments to see if BRT is as effective as CBT-I in improving the clinical symptomatology of insomnia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must meet DSM-5 criteria for insomnia disorder.
  • Adults aged 18 to 80 years
  • Capable of giving written informed consent.
  • Sufficient fluency in the study site's language (i.e., German or French) to understand all study-related information.

排除标准

  • Unstable, progressive, or degenerative medical condition
  • Acute pain or poorly managed chronic pain
  • Suicidality
  • Uncontrolled psychiatric condition requiring treatment outside of study
  • Alcohol or drug abuse or dependency
  • Diagnosis of psychosis, bipolar disorder, autism, borderline personality disorder, or antisocial personality disorder
  • Clinical evidence of sleep disorders other than insomnia (e.g., sleep apnea, restless legs, periodic limb movements in sleep, parasomnia)
  • Evidence of intellectual disability
  • Regular intake of benzodiazepines (BZD) or benzodiazepine receptor agonists (BZDRA)
  • Alteration of medication within 4 weeks prior to study treatment or planned alteration during the trial period (stable medication except BZD or BZDRA does not lead to exclusion)
  • Current other psychotherapy for insomnia
  • Known pregnancy or breastfeeding
  • Inability to comply with study procedure
  • Insufficient fluency in German or French to complete the study

结局指标

主要结局

Insomnia Severity Index (ISI) summary scores

时间窗: Baseline (T0) to 6 weeks (T1), 3 months (T2), and 6 months (T3)

次要结局

未报告次要终点

研究者

发起方
Christoph Nissen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Christoph Nissen

Prof. Dr. med.

University of Geneva, Switzerland

研究点 (4)

Loading locations...

相似试验

Comparative Efficacy of BRT and CBT-I for Insomnia | 临床试验